Immunogenicity and Safety of the Quadrivalent Adjuvant Subunit Influenza Vaccine in Seropositive and Seronegative Healthy People and Patients with Common Variable Immunodeficiency

Background. Influenza prophylaxis with the use of quadrivalent vaccines (QIV) is increasingly being introduced into healthcare practice. Methods. In total, 32 healthy adults and 6 patients with common variable immunodeficiency (CVID) received adjuvant QIV during 2018–2019 influenza season. Depending...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostinov, Mikhail P., Latysheva, Elena A., Kostinova, Aristitsa M., Akhmatova, Nelly K., Latysheva, Tatyana V., Vlasenko, Anna E., Dagil, Yulia A., Khromova, Ekaterina A., Polichshuk, Valentina B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712402/
https://www.ncbi.nlm.nih.gov/pubmed/33147763
http://dx.doi.org/10.3390/vaccines8040640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712402/
https://www.ncbi.nlm.nih.gov/pubmed/33147763
http://dx.doi.org/10.3390/vaccines8040640

Ejemplares similares